1. Home
  2. RJET vs SLDB Comparison

RJET vs SLDB Comparison

Compare RJET & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RJET

Republic Airways Holdings Inc.

N/A

Current Price

$17.42

Market Cap

930.0M

Sector

N/A

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$8.30

Market Cap

932.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RJET
SLDB
Founded
1982
2013
Country
United States
United States
Employees
8400
121
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.0M
932.9M
IPO Year
2009
2017

Fundamental Metrics

Financial Performance
Metric
RJET
SLDB
Price
$17.42
$8.30
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$16.36
AVG Volume (30 Days)
65.6K
825.9K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
15.43
34.97
EPS
1.26
N/A
Revenue
$1,676,500,000.00
$8,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.84
N/A
Revenue Growth
13.74
N/A
52 Week Low
$15.37
$3.79
52 Week High
$26.70
$11.45

Technical Indicators

Market Signals
Indicator
RJET
SLDB
Relative Strength Index (RSI) 41.01 37.66
Support Level $16.81 $6.25
Resistance Level $20.65 $8.67
Average True Range (ATR) 0.60 0.44
MACD -0.02 -0.20
Stochastic Oscillator 19.13 9.05

Price Performance

Historical Comparison
RJET
SLDB

About RJET Republic Airways Holdings Inc.

Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: